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Background: Flaxseed oil has the highest concentration of omega-3 α-linolenic acid, which has been associated
with cardiovascular benefit. However, the mechanism underlying the vascular effects induced through flaxseed oil
is not well known. Thus, in the present study, we investigated the effects of flaxseed oil on vascular function in isolated
rat aortic rings.
Methods: Wistar rats were treated daily with flaxseed oil or a control (mineral oil) intramuscular (i.m.) for fifteen days.
Isolated aortic segments were used to evaluate cyclooxygenase-2 (COX-2) protein expression, superoxide anion levels
and vascular reactivity experiments.
Results: Flaxseed oil treatment increased the vasoconstrictor response of aortic rings to phenylephrine. Endothelium
removal increased the response to phenylephrine in aortic segments isolated from both groups, but the effect
was smaller in the treated group. L-NAME incubation similarly increased the phenylephrine response in segments
from both groups. The TXA2 synthase inhibitor furegrelate, the selective COX-2 inhibitor NS 398, the TP receptor
antagonist SQ 29.548, the reactive oxygen species (ROS) scavenger apocynin, the superoxide anion scavengers
tiron and the phospholipase A2 inhibitor dexamethasone partially reversed the flaxseed oil-induced increase in
reactivity to phenylephrine.
Conclusions: These findings suggest that flaxseed oil treatment increased vascular reactivity to phenylephrine
through an increase in ROS production and COX-2-derived TXA2 production. The results obtained in the present
study provide new insight into the effects of flaxseed oil treatment (i.m.) on vascular function.
Keywords: Omega-3, Flaxseed oil, Aorta, Vascular reactivity, Oxidative stressBackground
The consumption of flaxseed and its components has
been associated with the prevention or reduction of
cardiovascular disease. Flaxseed contains a mixture of
fatty acids, primarily polyunsaturated fatty acids (PUFA),
comprising 57% omega-3 α-linolenic acid (ALA), 16%
omega-6 linoleic acid (LA) [1], and dietary fibers and
phytoestrogen lignans [2].
The lignan in flaxseed possesses potent antioxidant
effects [3], and PUFA have been associated with im-* Correspondence: ale_padilha@hotmail.com
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unless otherwise stated.provements in a variety of pathological conditions, such as
myocardial infarction, atherosclerosis and hypertension
[4-6]. Therefore, the cardiovascular effects of flaxseed
could be attributed not only to PUFA, but also to the
dietary fibers and phytoestrogen lignans presents in
these grains. Previous reports concerning the vascular
effect of flaxseed [7,8] have not provided evidence on
whether the cardiovascular effects of flaxseed could be
attributed to the PUFA present in the oil or the lignans
and fibers present in the seeds.
We previously demonstrated that treatment with soybean
oil for 15 days increases left ventricular performance with-
out affecting arterial blood pressure in rats [9]. Considering
the cardioprotective mechanisms induced through soybeanLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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we investigated whether flaxseed oil treatment would
produce vascular benefits. The effects of ALA on the
cyclooxygenase-2 (COX-2) pathway have been shown
to decrease thromboxane A2 (TXA2) and increase pros-
tacyclin 3 (PGI3) in vessels, such as the aorta [10-12],
which in turn, could augment endothelium-dependent
vasodilatation. However, LA has been shown to in-
crease series 2 prostaglandins and thromboxane, which
increases vascular tone [13]. However, there is limited
evidence regarding the vascular effects of flaxseed oil,
which is rich in PUFA, such as ALA. Thus, the primary
aim of the present study was to investigate the effects
of flaxseed oil treatment on endothelium-dependent
vascular reactivity.
As ALA is highly susceptible to oxidation, flaxseed oil
could also induce lipid peroxidation [14,15], which might
adversely effect the protection of the vascular system.
Thus, a secondary aim of this study is to verify the influ-
ence of flaxseed oil treatment on reactive oxygen species
(ROS) and COX-2 pathways.
Results
No difference in body weight was observed between
the groups either before (control = 250 ± 2.6 g, n = 21;
flaxseed oil = 254 ± 2.47 g, n = 17; P > 0.05) or after
(control = 314 ± 2.83 g, n = 21; flaxseed oil = 318 ± 2.16 g,
n = 17; P > 0.05) treatment.
Flaxseed oil treatment did not affect the response to
KCl (control = 2.26 ± 0.14 g, n = 21; flaxseed oil = 2.13 ±
0.12 g, n = 17; P > 0.05) or the vasodilator responses
induced through sodium nitroprusside or acetylcholine
(Figure 1A and B, respectively) in the isolated aortic rings
of treated rats compared with the controls. However,
the maximal response to phenylephrine was increased
in the aortic rings of flaxseed oil-treated rats, without
modifying the sensitivity (control = 6.69 ± 0.06, n = 18;
flaxseed oil = 6.68 ± 0.10, n = 16; P > 0.05) (Figure 1C).
To evaluate the influence of the endothelium on the
increased maximal response to phenylephrine, we mech-
anically removed the endothelium. Endothelium removal
increased the response to phenylephrine in aortic segments
isolated from both groups, but the effect was smaller in the
treated group, as shown in Figure 2. This result suggests
that flaxseed oil treatment reduces negative endothelial
modulation.
To evaluate whether flaxseed oil treatment alters NO
modulation of the contractile responses induced through
phenylephrine, the aortic rings were incubated with the
nitric oxide synthase (NOS) inhibitor L-NAME (100 μM).
L-NAME induced a similar left shift of the concentration
response curve towards phenylephrine in aortic segments
isolated from both groups and induced a similar contrac-
tion, as shown by the dAUC values (Figure 3). Thesefindings suggest that flaxseed oil treatment did not affect
NO production.
Next, we investigated whether vasoconstrictor prosta-
noids played a role in the enhanced responses to phenyl-
ephrine in the aortic rings from flaxseed oil-treated rats
using the non-selective cyclooxygenase inhibitor, indo-
methacin (10 μM). Indomethacin reduced the reactivity
to phenylephrine in aortic rings from both groups, but
the effect was greater in rings from the flaxseed oil-treated
group, as shown by the dAUC values (Figure 4). These re-
sults suggest that vasoconstrictor prostanoids are involved
in these responses. To clarify this issue, we investigated
whether COX-2 or TXA2 influenced the effects of flaxseed
oil treatment.
The aortic rings were separately incubated with the
COX-2 inhibitor NS 398 (1 μM), the TXA2 synthase
inhibitor furegrelate (10 μM) or the receptor antagonist
TP (TXA2 receptor - SQ 29.548, 1 μM). These inhibitors
reduced vascular reactivity in all preparations from flax-
seed oil-treated rats, but no alterations were observed in
preparations from the control group (Figure 5A, B, C, D,
E and F). We also examined COX-2 protein expression
and observed higher expression in flaxseed oil-treated
rats than in the controls (Figure 5G). These findings
suggest that flaxseed oil treatment promotes vasocon-
strictor prostanoid production through the COX-2 path-
way, generating TXA2.
In addition to COX-2-derived products, increased oxi-
dative stress also promoted vascular hyperreactivity
and endothelial dysfunction in the isolated aortic rings
of treated rats. Therefore, the influence of ROS in the
vascular response to phenylephrine after flaxseed oil
treatment was evaluated using the ROS scavenger,
apocynin (10 μM), the superoxide anion scavenger,
tiron (1 mM), and the hydrogen peroxide scavenger,
catalase (1000 U∙mL−1). Apocynin and tiron only reduced
the vascular reactivity in aortic rings from flaxseed oil-
treated rats (Figure 6A, B, C and D). However, catalase did
not affect phenylephrine responses in any group (Figure 6E
and F). In addition, we evaluated whether superoxide
anion production is altered after flaxseed oil treatment.
Figure 6G shows a significant increase in local superoxide
anion production in the aortic rings from flaxseed oil-
treated rats.
Moreover, dexamethasone (1 μM) was used to investigate
the putative role of phospholipase A2 on the increased vas-
cular reactivity to phenylephrine induced through flaxseed
oil treatment. The results showed that dexamethasone re-
duced the phenylephrine-induced contractile responses
in isolated aortic rings from flaxseed oil-treated, but
not control rats (Figure 7A and B).
However, the effect of flaxseed oil treatment on in-
flammatory parameter determined by C-reactive protein,
was not modified (Figure 8).
Figure 1 Effect of flaxseed oil treatment on the vascular relaxation and vasoconstrictor response. Concentration-response curves to sodium
nitroprusside (A), acetylcholine (B) and phenylephrine (C). *P < 0.05. The number of animals used is indicated in parentheses.
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The present study is the first to show that treatment (i.m.)
with flaxseed oil for two weeks increases the contractile
response induced through phenylephrine in the rat aorta.
This response is endothelium-dependent, and most likely
reflects an increase of COX-2-derived TXA2 and super-
oxide anion production.
Flaxseed oil has recently attracted much research at-
tention, as this seed is one of the richest vegetable oil
sources of ALA, associated with cardiovascular benefits,
and has lower amounts of LA; these compounds are
derived from the omega-3 (C18:3 n-3) and omega-6
(C18:2 n-6) families, respectively [4-6,16].
Flaxseed oil contains n-3 ALA, a precursor molecule
for the endogenous synthesis of f eicosapentaenoic acid
(EPA) and docosapentaenoic acid (DHA) [17]. LA, which
is present in lower amounts in flaxseed oil, is a precursor
molecule for the synthesis of arachidonic acid (AA) [17].
Some reports have demonstrated that EPA and DHA
prevent the development of hypertension [18,19] and
exhibit anti-atherothrombogenic effects [20]. These effects
might be induced, at least in part, through a decrease in
TXA2 and an increase in PGI3 in vessels, such as the aorta
[10-12]. Therefore, we investigated the effects of flaxseed
oil treatment on endothelial modulation in the vascular
responses induced through α-adrenoceptor activation inisolated aortic rings, as the aorta is a major artery suscep-
tible to atherosclerosis.
In the present study, we observed increased vascular
reactivity to phenylephrine in isolated aortic rings from
flaxseed oil-treated rats. However, the treatment did not
impair the endothelium-dependent relaxation induced
through acetylcholine. Similarly, the vascular response to
sodium nitroprusside was unaffected, suggesting that the
endothelial-independent routes through which vascular
relaxation is modulated were unaltered.
The effects of flaxseed on contractile and vasodilator
responses are controversial. A previous report showed that
feeding with a flaxseed-supplemented diet for 6, 8 or
16 weeks does not modify norepinephrine-induced vaso-
constriction or the relaxation response induced through
acetylcholine or sodium nitroprusside [7]. However, other
reports have shown that a high-flaxseed diet enhances
endothelial vasorelaxant function without reducing blood
pressure in hypertensive rats [8]. Flaxseed is a rich source
of plant lignans. The lignin secoisolariciresinol diglucoside
in flaxseed possesses potent antioxidant effects [3]. There-
fore, the improved endothelial vasodilatation, as previ-
ously demonstrated [8], could reflect the activities of
lignans. However, Ogawa et al. [21] demonstrated that
spontaneously hypertensive rats (SHR) fed a diet contain-
ing 10% flaxseed oil for four weeks did not show altered
Figure 2 Effect of flaxseed oil treatment on endothelial modulation of the vasoconstrictor response to phenylephrine. Phenylephrine
concentration-response curves after endothelium removal (A, B, C) in the aortic rings of control and flaxseed oil treated rats. E-: endothelium-denuded.
Difference in the area under the concentration-response curves (dAUC) in endothelium–denuded and intact segments (D). *P < 0.05. The number of
animals used is indicated in parentheses.
Figure 3 Effect of flaxseed oil treatment on NO modulation of the vasoconstrictor response to phenylephrine. Phenylephrine
concentration-response curves after L-NAME incubation (A, B) in the aortic rings of control and flaxseed oil treated rats. Difference in the area
under the concentration-response curves (dAUC) in the presence and absence of L-NAME (C). *P <0.05. The number of animals used is indicated
in parentheses.
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Figure 4 Effect of flaxseed oil treatment on prostanoid modulation of the vasoconstrictor response to phenylephrine. Phenylephrine
concentration-response curves in the aortic rings of control and flaxseed oil-treated rats after indomethacin (A, B) incubation. Difference in the
area under the concentration-response curves (dAUC) in the presence and absence of indomethacin (C). *P <0.05. The number of animals used is
indicated in parentheses.
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acetylcholine, although a significantly lower systolic blood
pressure was detected.
To investigate the role of the endothelium in the
increased phenylephrine responses induced through
flaxseed oil treatment in aortic rings, the experiments
in the present study were performed in the absence of
endothelium. Endothelium removal promoted an increase
in the phenylephrine-induced contraction in both groups,
but this effect was smaller in the aortic rings from
treated rats, suggesting that flaxseed oil affects endo-
thelial function. These results suggest that the ability of
the endothelium to negatively modulate the contractile
response induced by phenylephrine may be impaired in
isolated aortic rings of flaxseed oil-treated rats.
The increased vascular reactivity to phenylephrine and
concomitant reduction of endothelial modulation in
the aortic rings of treated rats might reflect reduced
NO bioavailability [22]. Therefore, L-NAME was used
to investigate the putative role of NO in the effects of
flaxseed oil treatment on the contractile responses
induced through phenylephrine. The results (Figure 3)
showed that the phenylephrine responses were similar
in the aortic rings of both control and treated rats,
suggesting that the flaxseed oil treatment did not affect
the endothelial-induced NO modulation of the vaso-
constrictor response. The data concerning the effects
of flaxseed oil on the nitric oxide pathway is limited
and controversial. Sekine et al. [23] demonstrated thatthe oral administration of 1 mL flaxseed oil for 5 days
reduces systolic blood pressure and increases prosta-
glandin I2 (PGI2) and NO release in SHR. However,
Karaca and Eraslan [24] showed that 0.1 ml flaxseed oil
administered through gavage for 30 days did not alter
nitric oxide levels in the heart, brain and liver of rats.
Flaxseed oil is rich in ALA. ALA and LA are synthe-
sized through a series of elongation and desaturation
reactions and can subsequently be incorporated into cell
membrane phospholipids [17]. EPA, DHA and AA act as
alternative substrates for both cyclooxygenase (COX)
and lipoxygenase (LOX) enzyme complexes, generating
series 3 prostaglandins and thromboxanes and series 5
leukotrienes (EPA +DHA) or series 2 prostaglandins and
thromboxanes and series 4 leukotrienes (AA) [25]. The
series 2 prostaglandins and thromboxanes increase vas-
cular tone. Therefore, to assess the participation of these
compounds, we used indomethacin to assess whether
vasoconstrictor prostanoids are involved in the increased
vascular reactivity to phenylephrine induced through
flaxseed oil treatment. Indomethacin reduced the response
to phenylephrine in aortic segments from both groups,
but this reduction was greater in the aortic rings of
flaxseed oil-treated rats, suggesting the increased par-
ticipation of the COX pathway. Moreover, NS 398, SQ
29.548 and furegrelate reduced the vasoconstrictor re-
sponses to phenylephrine in aortic segments from treated
rats, suggesting that vasoconstrictor prostanoids, specific-
ally TXA2, increase reactivity to phenylephrine induced
Figure 5 Effect of flaxseed oil treatment on vasoconstrictor prostanoids modulation of the vasoconstrictor response to phenylephrine.
Phenylephrine concentration-response curves in the aortic rings of control and flaxseed oil-treated rats after NS 398 (A, B), furegrelate (C, D) or
SQ 29,548 (E, F) incubation. Densitometric analysis of the western blot for COX-2 (G). Representative blots are also shown. *P <0.05. The number
of animals used is indicated in parentheses.
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Figure 6 Effect of flaxseed oil treatment on ROS modulation of the vasoconstrictor response to phenylephrine. Phenylephrine
concentration-response curves in the aortic rings of control and flaxseed oil-treated rats after apocynin (A, B), tiron (C, D) or catalase (E, F)
incubation. Vascular superoxide anion production in segments of aorta (G). Upper: representative fluorescent photomicrographs of confocal
microscopic arterial sections labeled with the oxidative dye hydroethidine. Below: vascular superoxide anion quantification. *P < 0.05. The number
of animals used is indicated in parentheses.
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Figure 7 Effect of flaxseed oil treatment on phospholipase A2 of the vasoconstrictor response to phenylephrine. Phenylephrine
concentration-response curves in the aortic rings of control and flaxseed oil-treated rats after dexamethasone (A, B) incubation. *P <0.05. The
number of animals used is indicated in parentheses.
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sults, we also observed that COX-2 protein expression
was greater in flaxseed oil-treated rats than in control rats.
Tou et al. [26] demonstrated that female rats fed a diet
supplemented with flaxseed oil for 8 weeks showed
decreased liver AA, and no significant differences in
the series 2 eicosanoids, PGE2 and TXB2 metabolites
were observed. However, Lee et al. [27] showed that the
aortic production of PGI2 and the serum concentration
of TXA2 were significantly low in rats fed a diet con-
taining flaxseed oil for 4 weeks. However, Rupp et al.
[10] showed an increased production of 6-keto-PGFlα, a
PGI2 by-product, in rats fed a diet supplemented with
flaxseed oil, although the arachidonic acid content was
greatly reduced. Sekine et al. [23] reported similar results,
showing that the plasma 6-keto-PGFlα levels were signifi-
cantly higher in the fed flaxseed oil diet group.
PGI2 is synthesized in response to the release of the
n-6 fatty acid AA from membrane phospholipids [25].
However, in addition to the increased PGI2, the n-6 LAFigure 8 Levels of C-reactive protein serum in control and
flaxseed oil-treated rats. P > 0.05. The number of animals used is
indicated in parentheses.could also increase other series 2 prostanoids, such as
TXA2, a potent vasoconstrictor [25]. Moreover, a previous
report demonstrated that high levels of PGI2 could induce
a vasoconstrictor response through the activation of the
TP receptor [28]. Although we did not measure levels
of PGI2 in the present study, this hypothesis cannot be
discarded.
Moreover, eicosanoids derived from PUFA, such as AA
and EPA, are physiologically active compounds that act
locally as signaling molecules through G protein-linked
receptors. When AA is predominantly incorporated into
cell membrane phospholipids under conditions, such as
injury or inflammation, phospholipase A2 might release
AA. Subsequently, intracellular signaling cascades might
elicit a wide range of responses, including vasoconstric-
tion, the activation of leukocytes, the stimulation of plate-
let aggregation and the generation of reactive oxygen
species [29]. These effects might increase vulnerability to
endothelial dysfunction and induce inflammation in the
vessel wall, which is a key factor in atherosclerosis [30].
Thus, we suggest that the increased TXA2 induced
through flaxseed oil treatment (i.m.) might increase
phenylephrine contractions, as observed in the present
study, through n-6 LA. Alterations in the eicosanoid
profile might have important effects on inflammation
[31]. The n-3 and n-6 PUFA compete for COX and LOX
enzymes. Moreover, the series 2 and series 4 eicosanoids
derived from n-6 PUFA are more biologically active than
the series 3 and series 5 eicosanoids derived from n-3
PUFA [32], even when present in smaller amounts [33].
Furthermore, series 2 and series 4 eicosanoids can induce
pro-inflammatory and pro-aggregatory states [34], likely
promoting increased vascular reactivity [34].
Therefore, we used the phospholipase A2 blocker, dexa-
methasone, to investigate whether phospholipase A2 me-
diates the effects induced through flaxseed oil treatment
in vascular reactivity. Dexamethasone abolished the effects
of flaxseed oil on the contractile response to the α1-
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could increase phospholipase A2 activity, which in turn,
increases eicosanoid production, leading to increased
series 2 and series 4 eicosanoid activity. The effect of
dexamethasone could be mediated through a reduction of
COX-2-derived TXA2 release in response to α-adrenergic
activation, as previously reported [35].
Glucocorticoids play an important role in the control of
vascular smooth muscle tone through the modification of
vasoconstrictor responses to different vasoactive agents
and through alterations in vascular prostanoid and/or
nitric oxide production [36,37]. Therefore, dexamethasone
could inhibit COX-2 in the isolated aortic rings of flaxseed
oil-treated rats, normalizing vascular reactivity to the con-
trol group level. In addition to COX-2-derived products,
the increased oxidative stress could also promote vascular
hyperreactivity and endothelial dysfunction in aortic
rings isolated from treated rats. The results demonstrated
that apocynin, a ROS scavenger, and tiron, a cell permeant
non-enzymatic scavenger of O2
.–, decreased vascular reactiv-
ity to phenylephrine in aortic rings isolated from treated
rats, suggesting that flaxseed oil exposure increases ROS,
primarily O2
.–, and induces oxidative stress.
Consistent with these findings, we observed an increase
of local superoxide anion production in the aortic rings
from flaxseed oil-treated rats. However, incubation with
catalase did not alter the vascular contractile responses in
both groups, suggesting that flaxseed oil treatment did not
affect the release of hydrogen peroxide. Martínez-Revelles
et al. [38] demonstrated that COX-2-derived products
modulate ROS production and also, ROS can activate
COX expression. Thus, we suggest that COX-2 prosta-
noids might increase ROS production and ROS might act
on COX-2 expression, although these COX-2-derived
products and ROS could operate independently.
However, to investigate whether the flaxseed oil treat-
ment could induce an inflammatory state, we evaluated
serum C-reactive protein levels. Our results demonstrated
that the flaxseed treatment did not modify this parameter.
Flaxseed oil has variable effects on the inflammatory
mediators that seem to be dose- and time- dependent.
Lower doses do not affect TNF-a, IL-1b, IL-6, or soluble
intracellular adhesion molecule-1 (sICAM-1) in healthy
adults [39]. However, higher concentrations of flaxseed oil
decrease the levels of cytokines [40]. Moreover, 4 months
of flaxseed oil supplementation appears to reduce the
C-reactive protein levels [41].
A previous report demonstrated that flaxseed oil treat-
ment increases lipid peroxidation and oxidative stress
and reduces SOD activity [42]. Another report showed
that flaxseed oil does not affect catalase activity or super-
oxide dismutase in monkey livers in vivo and in vitro
[43]. Although we did not measure SOD activity, these
results suggest that flaxseed oil treatment increasedROS production, primarily the superoxide anion, with-
out increasing hydrogen peroxide.
However, although the present study demonstrated in-
creased ROS production, a recent study showed that the
combined effect of flaxseed oil and astaxanthin, a natural
antioxidant, in rats fed a high-fat diet efficiently amelio-
rates oxidative stress, lipid profile and inflammation [44].
However, as mentioned above, flaxseed oil was also
reported to promote and increase lipid peroxidation [42].
Consistently, Nestel et al. [14] demonstrated that ALA
reduces HDL and increases LDL plasmatic levels, likely
reflecting high intake of ALA and increased vulnerability
of polyunsaturated fatty acids to oxidation. This effect
might alter the negative modulation of vascular tone in
the endothelium, as shown in the present study.
In conclusion, the present study demonstrated that
flaxseed oil treatment increases the vascular reactivity
to phenylephrine and is associated with increased ROS
production and the increased participation of COX-2
derivatives. Moreover, this treatment could increase
phospholipase A2 participation, which in turn could
increase the production of COX-2 inflammatory deriva-
tives. Thus, the results of the present study provide
new insights into the effects of flaxseed oil on vascular
function.Materials and methods
Animals and treatment
Male Wistar rats (250–300 g) were used in this study.
The care and use of laboratory animals were in accord-
ance with the Guide for the Care and Use of Laboratory
Animals, and the protocols were approved through the
Ethics Committee of the Federal University of Espirito
Santo (038/2012 CEUA-UFES). During treatment, the rats
were provided free access to tap water and fed standard
chow ad libitum.
The rats were divided in two groups: flaxseed oil treat-
ment or control. The treated group received a daily dose
of 0.1 mL intramuscular (i.m.) of flaxseed oil for two
weeks [9], and the control group received the same
amount of mineral oil for the same time period. Notably,
we used i.m. flaxseed oil injections to ensure that all rats
received the same daily dose.
At the end of the treatment, the rats were anesthetized
with urethane (1.2 g/kg, ip). The serum samples were
collected and stored at −80°C until they were used to
assess C-reactive protein. The thoracic aortas were
carefully dissected, and the connective tissue was re-
moved. For vascular reactivity experiments, the aortas
were divided into cylindrical segments of 4 mm in
length. To analyze the expression of COX-2 isoforms
and evaluate O2
.– production in situ, the aortic segments
were frozen at −80°C until the day of analysis.
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The aortic segments, 4 mm in length, were mounted in an
organ bath at 37°C containing 5 mL Krebs-Henseleit
solution (in mM: NaCl 118, KCl 4.7, NaHCO3 25, CaCl2-
2H2O 2.5, KH2PO4 1.2, MgSO4–7H2O 1.2, glucose 11 and
ethylenediamine-tetraacetic acid (EDTA) 0.01), continu-
ously gassed with a 95% O2-5% CO2 mixture (pH 7.4).
The arterial segments were stretched to an optimal resting
tension of 1 g. The isometric tension was recorded using
a force transducer (TSD125C, BIOPAC Systems, Santa
Barbara, CA, USA) connected to an acquisition system
(MP100, BIOPAC Systems).
After a 45-min equilibration period, all aortic rings
were exposed twice to 75 mM KCl (30 min each), to
examine the functional integrity of the samples and
assess the maximal induced tension. Subsequently, the
endothelial integrity was examined using acetylcholine
(10 μM) on segments previously treated with phenyleph-
rine (1 μM). A relaxation equal to or greater than 90%
was indicative of functional integrity in the endothelium.
After a washout period (30 min), increasing concentra-
tions of phenylephrine (0.1 nM to 0.3 mM) were applied.
A concentration-response curve to this agonist was
obtained, and the maximal tension was measured upon
reaching a plateau.
The influence of the endothelium on the response to
phenylephrine was examined through the mechanistic
removal of the tissue (rubbing the lumen with a needle).
The absence of endothelium was confirmed based on
the inability of 10 μM of acetylcholine to produce
relaxation, and the functional integrity of the vessel was
evaluated through KCl contraction. When the integrity
of the vessel was damaged, the rings were discarded.
The role of endothelium-derived vasoactive factors in the
phenylephrine-elicited contractile response was examined.
The effects of the following drugs were evaluated: the
nonspecific NOS inhibitor N-nitro-L-arginine methyl
ester (L-NAME, 100 μM), an inhibitor phospholipase A2
(dexamethasone, 1 μM), a non-selective cyclooxygenase
inhibitor (indomethacin, 10 μM), a COX-2 inhibitor (NS
398, 1 μM), a TP receptor antagonist (SQ 29.548, 1 μM), a
TXA2 synthase inhibitor (furegrelate, 1 μM), a ROS scav-
enger (apocynin, 10 μM), a superoxide anion scavenger
(tiron, 1 mM) and a hydrogen peroxide scavenger (cata-
lase, 1000 U.mL−1). These drugs were added at 30 min
prior to the generation of phenylephrine concentration-
response curves.
In another set of experiments, following the 45-min
equilibration period, aortic rings were treated with
phenylephrine (1 μM) until a plateau was reached
(approximately 15 min), and concentration-response
curves to acetylcholine (0.01 nM to 30 μM) or sodium
nitroprusside (0.01 nM to 30 μM) were obtained for
both groups.In situ detection of vascular O2
.– production
The oxidative fluorescent dye dihydroethidium (DHE)
was used to evaluate O2
.–production in situ, as previously
described [45]. Hydroethidine freely permeates cells,
and in the presence of O2
.–, this compound is oxidized
to ethidium bromide, which is trapped through DNA
intercalation. Ethidium bromide is excited at 546 nm
and emits light at 610 nm. The frozen tissue segments
were dissected into 10-μm-thick sections and placed on a
glass slide. The serial sections were equilibrated under
identical conditions for 30 min at 37°C in Krebs-HEPES
buffer (in mM: 130 NaCl, 5.6 KCl, 2 CaCl2, 0.24 MgCl2,
8.3 HEPES, and 11 glucose, pH 7.4). Fresh buffer contain-
ing DHE (2 μM) was applied topically to each tissue
section. Subsequently, the sections were coverslipped
and incubated for 30 min in a light-protected humidified
chamber at 37°C, followed by imaging using an inverted
fluorescence microscope Leica DM 2500 with a 40× object-
ive and a Leica DFC 310 FX camera, using the same im-
aging settings for control and flaxseed oil-treated samples.
The fluorescence was detected using a 568-nm long-pass
filter. For quantification, eight frozen tissue segments per
animal were sampled for each experimental condition and
averaged. The mean fluorescence densities in the target
region were calculated using ImageJ software.Western blot analysis of COX-2 expression
COX-2 protein expression was detected in homogenates
from the aortic segments of control and flaxseed oil-treated
rats, as previously described [46]. The proteins in the
homogenates were separated through 10% SDS-PAGE
and subsequently transferred to nitrocellulose membranes,
followed by incubation with mouse monoclonal antibodies
for COX-2 (1:200; Cayman Chemical; Ann Arbor, MI,
USA). After washing, the membranes were incubated
with an anti-mouse immunoglobulin antibody conjugated
to horseradish peroxidase (1:5000, StressGen, Victoria,
Canada). After thorough washing, the immunocomplexes
were detected using an enhanced horseradish peroxidase/
luminal chemiluminescence system (ECL Plus, Amersham
International, Little Chalfont, UK) and film (Hyperfilm
ECL - International). The signals on the immunoblot were
quantified using the National Institutes of Health Image
V1.56 software. The same membrane was used to detect
β-actin expression using a mouse monoclonal antibody
(1:5000, Sigma, USA).Measurement of C-reactive protein
The C-reactive protein concentrations were measured in
serum simples by turbidimetry (Integra 4000), after im-
munoprecipitation with RCPLX (Roche/Hitachi cobas c)
at the University Hospital Cassiano Antônio Moraes.
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The vasoconstrictor responses induced through phenyl-
ephrine were normalized to the contraction induced
through 75 mM KCl and expressed as a percentage of
this contraction. The vasodilator responses are expressed
as a percentage of the previous phenylephrine contraction.
For each concentration-response curve, the maximum
effect (Rmax) and the concentration of the agonist that
produced one-half of the Rmax (EC50) were calculated
using nonlinear regression analysis (GraphPad Prism
Software, San Diego, CA). The sensitivity of the agonists is
expressed as pD2 (−log EC50). To compare the effects of
L-NAME, indomethacin and endothelium denudation on
the contractile response to phenylephrine, the differences
in the area under the concentration-response curves
(dAUC) for phenylephrine under control and experimen-
tal conditions were calculated. The AUCs were calculated
from the individual curve plots (GraphPad Prism Soft-
ware), and the differences are expressed as the percentage
of the AUC for the corresponding control. These values
indicate differences in the magnitude of the effect of each
treatment in the control and flaxseed oil-treated rats. The
results are expressed as the means ± SEM of the number
of rats studied, and the differences were analyzed using
Student’s t-test and two-way ANOVA for comparisons
between groups. When ANOVA showed a significant
treatment effect, Bonferroni’s post hoc-test was used to
compare individual means. Differences were considered
statistically significant at P-values < 0.05.
Drugs and reagents
Flaxseed oil and dexamethasone were purchased from
Cacalia Comercial Ltda (natural products) and Alquimia
Compounding Pharmacy, respectively. L-NAME, 1-phenyl-
ephrine hydrochloride, indomethacin, NS 398, SQ 29.548,
furegrelate, acetylcholine chloride, sodium nitroprusside,
apocynin, tiron and catalase were purchased from Sigma-
Aldrich (St. Louis, USA). All salts and reagents were
analytical grade and obtained from Sigma-Aldrich or
Merck (Darmstadt, Germany).
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